Hereditary breast and ovarian cancer predisposition management for asymptomatic patient carrier of a BRCA mutation

被引：0
|
作者：
Bonfanti, Arianna [1 ]
Cordier, Christophe [1 ]
机构：
[1] Synlab, Lausanne, Switzerland
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2022年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P22.002.A
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [21] Breast and ovarian cancer due to BRCA1&2 hereditary cancer predisposition syndrome and reproduction: Literature review
    Jegu, M.
    Der, A. Some
    Morcel, K.
    Abadie, C.
    Fritel, X.
    Leveque, J.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2015, 44 (01): : 10 - 17
  • [22] Management of non-BRCA breast cancer predisposition
    Robson, M.
    CANCER RESEARCH, 2016, 76
  • [23] Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
    Ying Liu
    Jing Zhu
    Xiao Wei
    Duoxia Yang
    Si Li
    Xiaoping Qian
    Li Li
    Journal of Ovarian Research, 15
  • [24] Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
    Liu, Ying
    Zhu, Jing
    Wei, Xiao
    Yang, Duoxia
    Li, Si
    Qian, Xiaoping
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [25] Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer
    Eisen, A
    Rebbeck, TR
    Wood, WC
    Weber, BL
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1980 - 1995
  • [26] Hereditary predisposition to breast and ovarian cancer linked to BRCA1 and BRCA2:: a disease of the genotoxic damage repair processes
    Feunteun, J
    M S-MEDECINE SCIENCES, 1999, 15 (01): : 38 - 44
  • [27] Management of hereditary breast and ovarian cancer
    Hideko Yamauchi
    Junko Takei
    International Journal of Clinical Oncology, 2018, 23 : 45 - 51
  • [28] Management of hereditary breast and ovarian cancer
    Yamauchi, Hideko
    Takei, Junko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 45 - 51
  • [29] Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families.
    Schmutzler, R
    Schwarz-Boeger, U
    Bastert, G
    Deininger, J
    Hahn, W
    Kast, K
    Prieshof, B
    Volm, T
    Kiechle, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 889S - 889S
  • [30] Hereditary breast and ovarian cancer:: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers
    Llort, Gemma
    Blanco, Merce Peris e Ignacio
    MEDICINA CLINICA, 2007, 128 (12): : 468 - 476
12345